Opposition · USPTO

Opposition 91264591

OtherUSPTO

Opposition 91264591 at USPTO between Hyper Ice, Inc. and Mediqueens Korea LLC, over the mark HM HYPER MUSCLE, filed Sep 4, 2020. Status in the office record: other.

View HM HYPER MUSCLEGet this data via the API
Status
Other
Result
Other
Filed
Sep 4, 2020
Marks involved
10
Parties

Who is involved

The parties as named in the office record.

Opponent

Hyper Ice, Inc.

Respondent

Mediqueens Korea LLC

Timeline

How the case has moved

Dates from the USPTO record and the HM HYPER MUSCLE filing.

  1. HM HYPER MUSCLE filed

    Application 88790739 filed at the USPTO.

  2. Opposition filed

    Hyper Ice, Inc. started opposition 91264591 at USPTO against HM HYPER MUSCLE.
Marks

Marks involved

1 contested mark, 9 marks the challenger relies on.

MarkRoleApplicationOffice
HM HYPER MUSCLEContested88790739USPTO
HYPERICERelied on85146782USPTO
HYPERICERelied on86745857USPTO
HYPERSPHERERelied on87093177USPTO
HYPERSOOTHERelied on87150939USPTO
HYPERVOLTRelied on87243201USPTO
HYPERICERelied on87512959USPTO
HYPERICERelied on87523876USPTO
HYPERTOONSRelied on87529002USPTO
HYPERICERelied on87541587USPTO
API

Get this data via the API

Every fact on this page comes from the Signa API. Track oppositions and cancellations on any mark with one request.

  • GET/v1/proceedings/{id}

    Parties, dates, outcome and every mark in the case

  • GET/v1/proceedings?trademark_id={trademark_id}

    Every proceeding on a mark

Get API keyView docs
GET /v1/proceedings/{id}
ID=prc_142dbc61-5563-4d44-965b-6ff160d9b134
curl https://api.signa.so/v1/proceedings/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "prc_142dbc61-5563-4d44-965b-6ff160d9b134",
  "object": "proceeding",
  "proceeding_type": "opposition",
  "proceeding_number": "91264591",
  "status": "other",
  "office_code": "US",
  "filed_date": "2020-09-04",
  "parties": [
    {
      "name": "Hyper Ice, Inc.",
      "role": "opponent"
    },
    {
      "name": "Mediqueens Korea LLC",
      "role": "respondent"
    }
  ]
}